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Depression, a sequela of stroke, is underrecognized and underreported. The American 
Heart/Stroke Association estimated 1/3 of patients develop depression after a stroke. 
Depression after a stroke has negative influence on stroke recovery through decreased 
participation in rehabilitation, and increased morbidity and mortality. The American 
Heart/Stroke Association recommended that depression screening be conducted on stroke 
patient; however, there is a lack of guidance regarding the optimal time and tools for 
depression screening. The practice problem identified was the absence of depression 
screening in poststroke patients at the project site. The project question focused on 
identifying evidence-based approaches for depression screening in poststroke patients.  
The goal of the project was to develop clinical practice guidelines for depression 
screening poststroke. The framework used to develop the project was the John Hopkins 
Evidence-Based Nursing model. An expert panel was used to evaluate the developed 
clinical practice guidelines. Serving as participants, expert panelist were selected based 
on their background in stroke care management. Panelists evaluated the guidelines using 
the Appraisal of Guidelines for Research and Evaluation Instrument II standard 
instrument tool. Twenty-five percent of reviewers recommended using the guidelines and 
75% recommended using the guidelines with minor modifications. Implementation of 
clinical practice guidelines support depression screening after stroke leading to increased 
awareness, education, recognition and reporting. The findings of this project have the 
potential for positive social changes by improving depression screening in stroke patients 
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Section 1: Nature of the Project 
Introduction 
Depression in the poststroke patient has been documented in the literature as 
having a negative impact in clinical outcomes (Jia et al., 2010). The occurrence and 
impact of depression may vary depending on the severity of disability and location of 
cerebral infarct (Kouwenhoven, Kirkevold, Engedal, & Kim, 2011). Depression in 
poststroke patients can lead to fatigue, pain, and failure to participate in rehabilitation 
activities (Lerdal et al., 2011). Stroke is the leading cause of disability in the United 
States, with 20% of people requiring institutional care 3 months poststroke (Hollender, 
2014). It has been estimated that approximately one third of stroke patients will be 
affected by depression (Hollender, 2014). Kouwenhoven, Kirkevold, Engedal, and Kim, 
(2011), stated that the incidence of poststroke depression is higher within 1-month post 
stroke than later phases. 
Stroke is the leading cause of disability, which can result in life changing 
alterations for the stroke survivor. Depending on the severity of the stroke, the survivor 
may have limitations on the degree of independence, subsequently affecting their quality 
of life and participation in the life known before the stroke (Kouwenhoven, Kirkevold, 
Engedal, & Kim, 2012). Although the survivor is alive, it can be assumed there is a 
perception of loss. Poststroke depression is associated with physical disability, stroke 
severity, history of depression, and cognitive impairment (American Heart Association 
Stroke Council, 2017). Additionally, poststroke depression is attributed to poorer 
functional outcome (American Heart Association Stroke Council, 2017). The American 
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Heart Association Stroke Council, (2017) stated that one in three stroke survivors suffers 
from depressive symptoms because of biological and psychosocial factors. However, in 
lieu of the prevalence of poststroke depression, there is no standard or guidelines for 
screening of depressive symptoms in this population. 
This evidence-based project relates to the Doctor of Nursing Practice (DNP) 
Essential II: Organizational and Systems Leadership for Quality Improvement and 
Systems Thinking, with emphases on the DNP students’ leadership roles in recognizing 
health care issues and use of evidence-based knowledge to improve patient health 
outcomes (American Association of Colleges of Nursing [AACN], 2006). The AACN 
(2006) further detailed DNP Essential III: Clinical Scholarship and Analytical Methods 
for Evidence-Based Practice, which focuses on the DNP students’ ability to interpret, 
spread, and assimilate research into evidence-based practice. Implementation of 
evidence-based practice is not an uncommon occurrence within the acute care setting. 
However, when existing guidelines neglect to include hospital organizations, 
subsequently the discussion changes to “is this guideline best practice and should the 
organization adopt it?” According to Campos (2011), evidence-based practices are 
interventions or programs that have been rigorously scientifically evaluated for 
effectiveness, whereas best practice lack independent evaluation of effectiveness. 
The nature of the DNP project was to develop a clinical practice guideline based 
on the evidence to facilitate a process for depression screening in poststroke patients, 
ultimately leading the organization to implement the guideline. An additional implication 
of the DNP project was to impact social change through adoption of the guideline across 
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the system and into the clinical setting. An additional impact for social change included 
presentation of clinical guidelines at various conferences and meetings as appropriate. 
Problem Statement 
The problem that was addressed in the evidenced-based project is the lack of 
depression screening in the poststroke patient as evidenced by non existing tools, policies 
or procedures. While recent reports indicate over 1,500 patients have been treated for 
stroke at the project site, data on how many of those patients have reported symptoms 
related to depression is unknown. In a recent statement by the American Heart 
Association Stroke Council (2017), depression affects one third of stroke survivors and is 
associated with poor functional outcomes and increase mortality. Most patients, 
approximately half of stroke survivors, are discharged home with persistent neurological 
impairments (Andersen et al., 2000). Readmission rates within 1 year of stroke range 
from 20% to 27% (Andersen et al., 2000). Increase health care costs and emotional 
distress are associated with readmission of the stroke patient, a common occurrence in the 
acute care setting (Andersen et al., 2000). 
The Joint Commission standards for primary stroke center details essential 
requirements for the stroke program. In the disease specific requirements chapter titled 
Delivering or Facilitating Clinical Care, (DSDF) Element 4 provides specific 
requirements to address the plan of care that is based on a needs assessment (The Joint 
Commission, 2017). In comparing the DSDF Element 4 in a Primary Stroke Center, a 
similar standard with the Comprehensive Stroke Center requirements, indicates that there 
is a notable difference. In the comprehensive center requirement, there is an element for 
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assessing the patient for depression, cognitive decline, and other social issues prior to 
discharge (The Joint Commission, 2017), however the primary stroke center standards do 
not have this as a requirement. Recently, the standards for a comprehensive certified 
center have been updated, eliminating the requirement for depression screening (The 
Joint Commission, 2018). Prior to this recent update, this difference led to variation in 
practice in the delivery of patient care and potential outcomes among the stroke patients 
treated in a primary stroke center versus a comprehensive stroke center. 
The stroke population characteristics between a primary care center and a 
comprehensive care center are relatively the same with the major difference being 
available intervention options. Although there is not a consistent standard between the 
primary center certification and the comprehensive center certification regarding 
depression screening, there is a recommendation by the U.S. Preventive Services Task 
Force (USPSTF) for depression screening in all adult patients. 
The number of stroke survivors will likely increase because of the improvements 
in the management of acute strokes (Lightbody et al., 2007). Subsequently, this leads to 
an increase number of individuals living with a disability either physically or cognitively 
(Lightbody et al., 2007). Nursing practice has long held an interest in improving patient 
outcomes and nurses possess the skills to assess factors that will have a negative impact 
on them. Nursing can play an active role in recognition and management of poststroke 
depression, a common consequence of a stroke (Lightbody et al., 2007; Melrose, 2016), 




The primary aim of this DNP project was to develop a clinical practice guideline 
for depression screening in the poststroke patient. A clinical practice guideline can be 
defined as statements that include recommendations intended to optimize patient care that 
are informed by a systematic review of evidence and an assessment of the benefits and 
harms of alternative care options (Rosenfeld & Shiffman, 2009). 
The evidence is clear that poststroke patients have an increase propensity of 
developing depression, subsequently leading to poorer outcomes, decreased quality of 
life, increase readmission rates, and increase mortality (American Heart Association 
Stroke Council, 2017; Andersen et al., 2000; Robinson-Smith, Johnston, & Allen, 2000; 
Whyte & Mulsant, 2002). The opportunity between the recommendation of the evidence 
and current practice, can be lessened with a clinical practice guideline for depression 
screening in post stroke patients. 
Nature of the Doctorate Project 
The nature of this project involved development of a clinical practice guideline 
for depression screening. I used the John Hopkins Nursing Evidence-Based Practice 
model (JHNEBP) (Newhouse, John Hopkins University, Sigma Theta Tua International, 
& John Hopkins Hospital, 2007). The model described in detail later, consist of three 
phases. Using the JHNEBP model, the first phase identified absence of a clinical practice 
guideline to facilitate depression screening in poststroke patients as the practice problem. 
In accordance with the second phase of the JHNEBP model, my next step was to review 
the research and non research available for depression in poststroke patients. Sources of 
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evidence that I considered included original research papers, journal articles, organization 
recommendations, questionnaires, other evidence-based projects and systematic reviews. 
The final phase, translation, is where the feasibility of use of the clinical practice 
guideline will be evaluated with consideration of the external and internal factors (see 
Newhouse, John Hopkins University, Sigma Theta Tua International, & John Hopkins 
Hospital, 2007) Also, in the last phase, the evaluation of the guideline was collected, 
analyzed and disseminated to the stakeholders of the organization. 
The evidence-based project involved several actions. First, I used JHNEBP to 
facilitate a review of the evidence and evaluate internal and external factors as it related 
to the development of the clinical practice guideline (see Newhouse, John Hopkins 
University, Sigma Theta Tua International, & John Hopkins Hospital, 2007). Second, the 
literature was critically appraised, then synthesized. Following a synthesis of the 
literature, the clinical practice guideline was developed. Nearing the completion of the 
guideline, I identified members for expert panel review to provide anonymous feedback 
of the clinical guideline using the AGREE II instrument. I revised the guidelines based on 
the recommendations of the expert panel. At the end of completing the revision, another 
group was formed consisting of key stakeholders and end users. The purpose of the 
second group was to discuss usability and validate content. The final steps of the process 
were to develop a final report and disseminate to key stakeholders. 
Significance of the Project 
Poststroke depression has a significant impact on the recovery of stroke survivors 
(Robinson-Smith et al., 2000). Despite the negative impact, there lacks a specific 
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guideline or protocol on when or how to screen for depression in poststroke patients. 
Although the USPSTF has recommended depression for all adults, it currently excludes 
settings such as hospitals or other acute care settings. In the DNP project setting key 
stakeholders included the stroke coordinator, the stroke program medical director, chief 
nursing officer, unit director of the primary stroke unit, unit leadership, and staff nurses. 
Nurses in the acute phase have the potential to significantly impact outcomes for the 
poststroke patient through identifying patients at risk for poststroke depression because of 
their proximity and education efforts across the continuum (Babkair, 2017; Klinedinst, 
Dunbar, & Clark, 2012; Stanfill, Elijovich, Baughman, & Conley, 2016). Because of the 
unique position of nursing in patient and family education, care givers and poststroke 
patients will have increased awareness of depressive signs. Consequentially, increasing 
the recognition and reporting of depressive signs in the poststroke patient has the 
likelihood of prompt treatment and lessen the stigma of depression (Klinedinst et al., 
2012). Early identification and treatment of depression in poststroke patients can have a 
positive impact on participation in rehabilitation and quality of life. 
Through the development of a clinical guideline, I hoped to increase awareness of 
poststroke depression while simultaneously facilitating a standardized approach to 
depression screening across the healthcare system. Dissemination of the clinical practice 
guideline at local and regional conferences would broaden the social impact to other 




Section 1 provided an overview of poststroke depression, impact of depression in 
poststroke patients, and current guidelines from the USPSTF. The practice problem that 
the DNP project addressed is development of a clinical practice guideline for depression 
screening in poststroke patients. The goal of this project was to develop an evidence-
based clinical practice guideline that facilitated screening in poststroke patients, a high-
risk group for depression. In the next section the background and context of depression in 
poststroke patients will be further explained. 
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Section 2: Background and Context 
Introduction 
The purpose of this DNP project was to develop a clinical practice guideline for 
depression screening in poststroke patients that include the following scope, purpose, and 
recommendations for depression screening. The goal of this project was to provide the 
clinical site with a clinical practice guideline that supports depression screening in 
poststroke patients. In this section concepts, relevance to nursing practice, local 
background and context, and the role of the DNP student are discussed. 
Concepts, Models and Theories 
For this project, I used the JHNEBP. The JHNEBP model is composed of three 
phases including practice, evidence, and translation (PET) (Newhouse et al., 2007). Phase 
1 consists of recognizing and identifying a practice problem to answer (Newhouse et al., 
2007). In this DNP project, the problem was the absence of a clinical practice guideline 
for depression screening in the poststroke patient. The second phase involved a 
comprehensive review of synthesis of research and non research evidence on the topic of 
the post stroke patient for depression. Lastly, the final phase was the implementation of 
the proposed change as a pilot study, in this instance a DNP project, measure outcomes, 
and dissemination of findings. The last phase of the JHNEBP model was demonstrated as 
evident by synthesis of the evidence to develop the guideline, review and validation from 
an expert panel, end user and stakeholder feedback, creation of a final report, and 
dissemination of the clinical guideline for recommendations. Other concepts of the model 
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are the influence of internal and external factors in implementation of the proposed 
change (see Newhouse et al., 2007). 
This model is an open system that consist of several related components. The 
outputs from the JHNEBP are influenced by internal and external factors (see Newhouse 
et al., 2007). The model, which is a process that facilitates translating evidence into 
practice, steps include identifying the evidence-based practice question, researching the 
evidence, and translation of evidence into practice (see Newhouse et al., 2007). However, 
within each major element there are several steps that occur as one matriculates through 
the process. This model has been used extensively by nurses to implement practice 
changes on infection prevention programs, postoperative urinary retention, and alarm 
fatigue (Buchko & Robinson, 2012; Dillman, Mancas, Jacoby, & Ruth-Sahd, 2014; Mori, 
2015). 
Mori (2015) conducted a quality improvement project to improve outcomes in 
orthopedic patients undergoing total knee arthroplasty by implementation of evidence-
based practice guidelines to prevent surgical site infections. The JHNEBP model was 
used to implement an infection prevention program. The project used guideline 
recommendations from the Institute of Healthcare Improvement (IHI) on prevention of 
surgical site infections. The population involved included patients undergoing total hip 
arthroplasty (THA) and total knee arthroplasty (TKA). Based on the recommendations in 
the evidence, each THA and TKA patient would receive nasal swab testing for 
Methicillin-sensitive Staphylococcus aureus (MSSA) and Methicillin-resistant 
Staphylococcus aureus (MRSA) 2 weeks prior to surgery, a bath containing 
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Chlorhexidine Gluconate (CHG) was administered 5 days prior to surgery, the day before 
surgery and the morning of surgery, to decolonize patients who had a positive MSSA or 
MRSA swab test result. An additional process was implemented for those patients with 
negative results for MSSA or MRSA to receive decolonization timely prior to surgery 
(Mori, 2015). Implementing the evidence-based guidelines resulted in reduction in 
surgical site infections, from 5.3% prior to implementation of the evidence-based project 
to 0% 7 months after implementation (Mori, 2015). 
Buchko and Robinson (2012) conducted a project in a 43-bed adult postpartum 
gynecologic unit in a community teaching hospital studying women who recently 
underwent urogynecology surgery with postoperative urinary retention. The purpose of 
the project was to identify evidence and management for postoperative urinary retention 
in women who had urogynecology surgery and integrate it into an evidence-based 
protocol. Buchko and Robinson described how the JHNEBP model was used to facilitate 
development of an evidence-based algorithm to use in a pilot study to evaluate 
effectiveness of the postoperative urinary retention algorithm. 
Dillman, Mancas, Jacob, and Ruth-Sahd (2014) described a systematic literature 
review of patient outcomes in critically ill uninsured patients compared to the critically ill 
insured patients. The authors described how the JHNEBP model was used to conduct the 
literature review. After reviewing the literature in accordance with the model guidelines, 
results showed poorer patients who are critically ill have worse outcomes if uninsured 
(Dillman et al., 2014). Authors in the previously referenced studies demonstrated 
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application of the JHNEBP model to conduct evidence-based research. As detailed below 
evidence-based sources are a cornerstone in nursing research. 
In an addition to using the JHNEBP model in my DNP project, I incorporated 
evidence-based sources. Evidenced-based practice (EBP) is the careful incorporation of 
the best research evidence with clinical expertise and patient values and needs in the 
delivery of quality, cost effective health care (Grove, Burns, & Gray, 2013). EBP also 
affords opportunities for nursing care to be individualized, effective, streamlined, active 
and amplify effects of clinical judgement (Grove et al., 2013). Evidence-based protocols 
facilitate early recognition and early interventions in conditions that have the potential of 
negative consequences if not treated early. Cervical cancer, nutritional, breast cancer, and 
colon cancer screenings have had a positive impact on early identification and treatment 
of the respective diseases (Grove et al., 2013). Evidence-based sources are highly 
perceived in healthcare. These sources serve as guide to change practice or implement 
new process that will have a positive effect on the population. 
Relevance to Nursing Practice 
Depression has been demonstrated to be common in poststroke patients, occurring 
as early as 2 weeks up to 1 year following a stroke (Buga, Filfan, George, & Popa-
Wagner, 2015; Damush et al., 2008; Hermann et al., 2011; Hollender, 2014; Joubert et 
al., 2006; Kouwenhoven, Kirkevold, Engedal, & Kim, 2012). Depression is associated 
with poor functional outcomes and higher mortality rates in poststroke patients 
(American Heart Association Stroke Council, 2017). Lack of a protocol supports the need 
for clinical practice guidelines on how to assess for depression in the poststroke patient. 
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Adverse consequences of lack of screening include late recognition and identification of 
depression in poststroke patients (Klinedinst et al., 2012). Additional outcomes due to 
lack of standards for depression screening in the acute care setting in this population 
contributes to under recognition of potential depressive signs and subsequently delayed 
referral for treatment (Klinedinst et al., 2012). Depression after a stroke is relevant to 
nursing practice because of the associated poor functional outcomes, high mortality rates, 
and the lack of a standardize process for assessment of depressive symptoms. 
The USPSTF is an independent group of national experts in prevention and 
evidence-based medicine (US Department of Health & Human Services, 2012). This 
panel of experts works to improve the health of all Americans by making evidence-based 
recommendations about clinical preventive services such as screenings, counseling 
services, or preventive medications (U.S. Department of Health & Human Services, 
2012). In recent years, this agency has focused on recommendations addressing early 
identification of depression (US Department of Health & Human Services, 2012). The 
USPSTF recommends screening of all adult patients for depression regardless of risk 
factors (Siu & U.S. Preventive Services Task Force, 2016). The recommendations are 
based on substantial evidence that there are a variety of factors associated with 
depression including persons with chronic illness, other mental disorders, advanced age, 
disability, poor health status related to medical illness, complicated grief, chronic sleep 
disturbances, loneliness, and a history of depression (Siu & U.S. Preventive Services 
Task Force, 2016). However, within the acute care setting in the southern United States, 
which this DNP project is intended, there is no established tool in accordance with the 
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recommendations for depression screening. Considering that the USPSTF 
recommendation includes all patients in the acute care setting, in conjunction with 
recommendations from the American Stroke Association, I focused on a select high-risk 
population, the poststroke patient. 
Stroke is a common medical illness in the United States, affecting approximately 
over 600,000 cases annually (American Heart Association, 2015). A person may suffer 
major changes in their because of a stroke. Loss of health, occupation, social role, and 
independence are some adverse effects of a stroke (Whyte & Mulsant, 2002). Poststroke 
depression affects approximately a third of the stroke survivor population and is a 
significant world health problem (Buga et al., 2015). Depression affects approximately 
5.4 to 8.9% of nonstroke patients and accounts for more than $43 billion in medical care 
costs within the United States (Maurer & Darnall, 2012). Maurer and Darnall (2012) also 
reported that depression is projected to become the second largest cause of disability by 
2020. Symptoms of depression can be specific as depressed mood, loss of interest in 
activities, impaired concentration, feelings of guilt, and suicidal ideation, however the 
symptoms can be nonspecific (Maurer & Darnall, 2012). Nonspecific symptoms include 
abdominal pain, back pain, change in weight or appetite, constipation, fatigue, headache, 
insomnia or hypersomnia, joint pain, neck pain and weakness (Maurer & Darnall, 2012). 
Although symptoms of depression range from specific to nonspecific, there are risk 
factors that would place an individual at a higher susceptibility for depression. Chronic 
medical illness, chronic minor daily stress, chronic pain syndrome, family history of 
depression, female gender, low income, job loss, low self-esteem, low social support, 
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prior depression, single, divorced, widowed, traumatic brain injury, and younger are 
associated with the prevalence of depression (Maurer & Darnall, 2012). The USPSTF has 
made recommendation for recognition of general depression symptoms but within the 
broad classification at risk patients, the stroke patient has a higher risk of depression. 
Although generalized depressive symptoms include those referenced above, 
poststroke depression presents as fatigue, insomnia and psychomotor impedance (Buga et 
al., 2015). Buga et al. (2015) estimated that 30% of stroke survivors suffer from 
poststroke depression, which affects short-term and long-term rehabilitation. Additional 
consequences of poststroke depression include poor outcomes, delay in recovery, 
impaired cognition, decreased quality of life, and decreased treatment efficiencies, as 
well as having mortality rates three times higher when compared to those without 
depression (Buga et al., 2015). According to Buga et al., 40% of poststroke patients will 
have an onset of depression within 3 months after suffering from a stroke. In those 
patients with a likelihood of developing depression, 30% develop depression after 
hospital discharge (Buga et al., 2015). Consequently, poststroke patients who continue to 
suffer from depression also exhibit failure to follow treatment plans and irritability with 
personality changes (Buga et al., 2015). Although negative outcomes are associated with 
depression in poststroke patients, there is little guidance on the optimal process to screen 
poststroke patients regarding timing of conducting a depression screening. The primary 
recommendation for depression screening comes from the USPSTF, which recommends 
depression screening in all adults (Siu & U.S. Preventive Services Task Force, 2016). 
However, the recommendations currently appear to be limited to the primary care setting, 
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excluding acute care settings such as hospitals. Another limitation in the 
recommendations is the reference that screening should be implemented in settings that 
have adequate systems in place to provide accurate diagnosis, effective treatment and 
appropriate follow-up (Siu & U.S. Preventive Services Task Force, 2016). Depression 
after a stroke is a common sequela, despite the associated negative outcomes and 
prevalence of depression following a stroke there is a lack guidance for detection and 
reporting.  
Depression is a condition with high prevalence worldwide. Depression includes 
disorders of major depression, minor depression and dysthymia. Depression affects 
approximately 340 million people worldwide, with 18 million people suffering from 
depression in the United States (Egede & Ellis, 2010). Egede and Ellis (2010) reported 
that according to the World Health Organization depression is accountable for the highest 
proportion of burdens associated with non-fatal health outcomes accounting for 
approximately 12% total years lived with disability. Studies have demonstrated that 
depression is a major cause of morbidity, mortality and increased use of healthcare 
resources (Andersen et al., 2000; Kouwenhoven et al., 2011; Williams et al., 2011). 
It’s estimated that depression has a prevalence of 5.4 to 8.9 percent in the United 
States general population, subsequently affecting 5 to 13 percent of patients in the 
primary care setting (Maurer & Darnall, 2012). Depression is attributed to $43 billion in 
medical care and costs (Maurer & Darnall, 2012). While depression can be present in the 
absence of other conditions, there is a higher incidence of depression in the presence of 
other conditions such as chronic medical illness, chronic minor daily stress, chronic pain 
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syndrome, family history of depression, female sex, low income job/loss, low self-
esteem, low social support, prior history of depression, single/divorced/widowed, 
traumatic brain injury, and younger age (Maurer & Darnall, 2012). Depression has been 
associated with increased mortality, worsening preexisting conditions such as 
cardiovascular disease and diabetes, can lead to suicide (Hollender, 2014). 
Stroke is a common medical condition, with over 600,000 new cases annually 
(Whyte & Muslant, 2002; American Heart Association, 2015). In the United States, there 
are 4.5 million survivors, however this figure is projected to increase as the management 
of stroke continues to improve (Whyte & Muslant, 2002; American Heart Association, 
2015). Stroke results in changes in an individual’s life, there can be a significant amount 
of loss related to health, occupation, social role and independence. Subsequently major 
depression is a common occurrence after a stroke. Approximately one third of stroke 
victims will suffer from post stroke depression with a peak prevalence within the first 
year (American Heart Association Stroke Council, 2017). Post stroke depression is 
thought to complicate and delay stroke rehabilitation, subsequently leading to poorer 
outcomes (Kouwenhoven, Kirkevold, Engedal, & Kim, 2011). 
Kirkil, Deveci, Deveci, and Atmaca (2015) conducted a cross sectional study to 
investigate the prevalence and relationship of depression in chronic obstructive 
pulmonary disease patients (COPD). The investigators enrolled 80 COPD patients in the 
study. The results of the study showed that depression was diagnosed in 42 (52.5%) of 
the patients using the Beck Depression Inventory and 51 (63.8%) using the Hospital 
Anxiety and Depression Scale (Kirkil, Deveci, Deveci, & Atmaca, 2015). In addition to 
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identification of depression in COPD patients, the authors linked the depression 
symptoms exhibited to the stage of the disease. Results demonstrated the more advanced 
the stage of COPD, the greater the depressive symptoms. Depressed mood in COPD 
patients were linked to poorer outcomes (Kirkil et al., 2015). 
In a similar study, investigating the effect of anxiety and depression on self-care 
agency and quality of life the results demonstrated a correlation between depressive 
symptoms, self-care and quality of life in COPD (Yildirim, Asilar, Bakar, & Demir, 
2013). Yildirim, Asilar, Bakar, and Demir (2013) completed a study in Turkey evaluating 
the effects of COPD. The descriptive study had 135 hospitalized patients from January to 
June 2010, who met the inclusion criteria. The results yielded 85.6% of patients at risk 
for depression and 69.6% at risk for anxiety (Yildirim, Asilar, Bakar, & Demir, 2013). 
Self-care scores and quality of life had a negative correlation to the risk of depression and 
anxiety, meaning the lower the self-care score the lower the quality of life, while there 
was an increased risk of depression and anxiety (Yildirim et al., 2013). The conclusion of 
the study stated anxiety and depression have a disruptive impact of physical, 
psychological and social functioning, as well as an undesirable effect on treatment 
compliance and recovery (Yildrim, Asilar, Bakar, & Demir, 2013). 
Kouwenhoven et. al (2012) performed a qualitative study to describe the “lived 
experience” of stroke survivors with depressive symptoms in the acute phase of a stroke. 
The study consisted of nine participants in stroke and rehabilitation units in Norway, 
meeting the inclusion criteria. Participants engaged in 45 to 90 - minute interview 
sessions with the investigators occurring 4 and 7 weeks following the stroke. Two main 
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themes were generated from the study including feelings of being trapped and losing 
oneself. The authors stated that three of the participants referred to their feelings as 
depression, two as not depressed, and four made no reference to the term at all, however 
all had a score suggestive of depression according to the Beck Depression Scale 
(Kouwenhoven et al., 2012). Stroke survivors may not refer to the emotions as depressive 
symptoms, but describe them in relation to losses, despair and grief and these symptoms 
may not be viewed as clinical depression by healthcare providers (Kouwenhoven et al., 
2012). 
Robinson-Smith et al., (2000) conducted a longitudinal correlational descriptive 
design study investigating self-care, self-efficacy, quality of life and depression after 
stroke. Participants were identified by records of admission to three hospitals inside a key 
rehabilitation institution in northeastern United States. The purpose of the study was to 
determine the relationship of self-care, self-efficacy to functional independence, quality 
of life and depression after a stroke at one and six months. At the one - month time 
period, the study had 77 participants, however 14 did not participate at six months for 
assorted reasons, such as death, mental status change below target, relocation, spouse 
illness, and refusal (Robinson-Smith et al., 2000). Overall there were 63 participants 
included in both the one month and six-month interval. The results demonstrated lower 
rankings in independence and health, lack of job, sex life and personal control and lack of 
job and sex life at one month and six months respectively (Robinson-Smith et al., 2000). 
Additionally, in the six-month quality of life assessment participants reported lower 
quality of life regarding travel on vacation, pursuit of leisure activities, amount of stress 
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or worries, and the potential to have a long life. Symptomatic depression was identified in 
25% of the participants at one month, conversely at six months’ depressive symptoms 
were identified in 15% of the participants. In the one - month time frame, functional 
independence did not demonstrate a relationship to quality of life, however it did 
demonstrate a strong relationship to depression. According to the authors one month after 
a stroke, self-care and self-efficacy contributed to 51% of the variance in depression and 
coping 52% in quality of life. The authors reported statistically significant differences 
between one month and six months after stroke in the categories of self-care, self-
efficacy, quality of life and depression with a 95% confidence level. Robinson-Smith, 
Johnston, and Allen (2000), concluded that self-care, self-efficacy is related to quality of 
life and depression after stroke. 
Haung et al., (2014) conducted a study exploring factors associated with 
depression in older residents with stroke in long-term care facilities. The cross-sectional 
design spanned twenty-three institutions in southern Taiwan. The authors utilized 
purposive sampling, enrolling 111 participants that met criteria. The participants were 
screened for depression using the Taiwan Geriatric Depression Scale (TGDS). The 
authors reported 41 of the 111 participants experienced depression, 36.9% of the total 
group (Huang et al., 2014). Prevalence of depression was 45.7% in nursing homes, 36.2% 
in intermediate care facilities, and 22.2% in domiciliary care facilities, with low Barthel’s 
Index scores correlated to more depressive symptoms (Huang et al., 2014). The 
recommendation of the authors was depression screening for elderly residents with stroke 
on admission to long-term care facilities by the healthcare provider (Huang et al., 2014). 
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Joubert et al., (2006) performed a prospective randomized control trial in a stroke 
unit. Participants of the study were randomized to an intervention or control group and 
were followed over a 12-month period. The purpose of the study was to evaluate the 
effect of a shared care model on management of vascular risk factors for stroke according 
to approved best practice guidelines, effect of screening for post stroke depression by a 
validated telephone assessment method with feedback to the General Practitioner (GP). 
Additionally, in the context of a shared model, what is the effect of such a shared care 
model on stroke recurrence and long-term stroke related mortality? A total of 80 patients 
were randomized into the study, with 35 in the control and 45 in the intervention group 
(Joubert et al., 2006). Overall the researchers reported better management of risk factors 
in the intervention group when compared to the control group. In specific regards to 
depression approximately 45% of the control group screened as depressed at 12 months, 
compared with 20% of the intervention group that screened as depressed (Joubert et al., 
2006). 
Williams et al., (2011) conducted a quasi-experimental study. The purpose of the 
study was to assess pre-post change in depression screening and treatment using an 
electronic medical record-based system intervention in veteran ischemic stroke survivors 
receiving care at two VA Medical Centers over a four-year period. The study included 
652 participants, 278 veterans in the intervention group and 374 veterans in the control 
group. The authors reported post stroke depression screening was performed within six 
months for 85% of the intervention group compared with 50% of the control group, and 
the treatment action was received by 83% of the intervention group compared with 73% 
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of the control group who screened positive for depression (Williams et al., 2011). The 
authors concluded that automated depression screening in primary and specialty care can 
improve detection and treatment of post stroke depression. 
Lightbody et al., (2007) conducted a cross-sectional pilot study comparing clinical 
diagnosis of depression by a psychiatrist with two clinical interviews, using the Geriatric 
Mental State (GMS) exam and the Montgomery-Asberg Depression Rating Scale 
(MADRS), performed by a nurse. The study had 28 participants. Lightbody et. al (2007) 
reported the psychiatric clinical diagnosis (PCD) classified 25% of the patients as 
depressed, the MADRS and GMS classified 43% and 54% patients respectively as 
depressed. The PCD was performed by the psychiatrist while the MADRS and GMS was 
performed by nurses. The investigators further reported that when compared to the PCD, 
the GMS had a sensitivity of 71% (CI 29-96%), specificity of 67% (CI 43-85%), positive 
predictive value of 42% (CI 15-72%) and a negative predictive value of 88% (CI 62-
98%) (Lightbody et al., 2007). The overall efficiency of the GMS was 68% (CI 48-84%) 
(Lightbody et al., 2007). The MADRS had a sensitivity of 100% (CI 59-100%), 
specificity of 65% (CI 38-86%), positive predictive value of 54% (CI 25-81%) and 
negative predictive value of 100% (CI 72-100%), with an overall efficacy of 75% (CI 53-
90%) (Lightbody et al., 2007). Lightbody et al., (2007) concluded that nurses have an 
instrumental role in detecting, preventing, and managing the depression in the post stroke 
patient. 
McIntosh (2017) completed an evidence-based quality improvement project, a 
depression screening protocol in patients with acute stroke. The purpose of the quality 
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improvement project was to determine efficacy of an evidence-based depression 
screening protocol in early detection and treatment of post stroke depression and to 
identify any relationships between the protocol interventions, depression scores, and 
diagnosis (McIntosh, 2017). In the project nurses completed depression screening 
utilizing a validated tool on patients that had a confirmed diagnosis of stroke. The study 
used a convenience sample of 79 hospitalized patients with acute stroke (McIntosh, 
2017). Results yielded 48% of the participants were identified as being depressed as 
defined by a score >4 on the validated tool, patient health questionnaire 9 (PHQ-9). 
Additionally, patients who had positive depression screening were more likely to receive 
education on stroke and depression, in conjunction with being medically treated for 
depression before discharge (McIntosh, 2017). The project also demonstrated an increase 
in nurse’s documentation of screening results, (x2=9.19, p=.002). Mcintosh (2017) 
concluded that an evidence-based depression screening protocol improved early detection 
and treatment of post stroke depression in hospitalized patients in the acute care setting. 
Melrose (2016) wrote an article centered on the nursing role in identification of 
post stroke depression. Post stroke depression has been associated with poor recovery and 
rehabilitation response, reduced social interactions, increase utilization of healthcare 
services, increased rates of cardiac and stroke sequalae, and increased mortality rates 
(Melrose, 2016). Melorose (2016) stated recognizing and responding to depression is a 
priority for nurses and formal caregivers knowing prevalence of post stroke depression is 
10% - 50% in stroke survivors. Post stroke depression can have extended durations, for 
several years if not treated (Melrose, 2016). Scales and questionnaires are valuable 
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resources that can aid a nurse in the assessment of post stroke depression (Melrose, 
2016). 
Screening for post stroke depression has historically been considered a condition 
associated with primary care, not in the acute care (hospitalized) setting. However acute 
care settings have implemented various processes to address depression screening, as a 
response to the previous Joint Commission Disease Specific Certification (L. Durm, 
personal communication, September 18, 2017). 
The goal of the DNP project was to develop a clinical practice guideline for post 
stroke depression screening. The desired impact of the clinical practice guideline was to 
provide a standard and process for depression screening in the post stroke patient. 
Local Background and Context 
Depression is a condition with high prevalence worldwide. Depression includes 
disorders of major depression, minor depression and dysthymia. Depression affects 
approximately 340 million people worldwide, with 18 million people suffering from 
depression in the United States (Egede & Ellis, 2010). Egede and Ellis (2010) reported 
that according to the World Health Organization depression is accountable for the highest 
proportion of burdens associated with non-fatal health outcomes accounting for 
approximately 12% total years lived with disability. Studies (Andersen et al., 2000; 
Kouwenhoven, Kirkevold, Engedal, & Kim, 2011; Williams et al., 2011) have 
demonstrated that depression is a major cause of morbidity, mortality and increased use 
of healthcare resources. 
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It’s estimated that depression has a prevalence of 5.4 to 8.9 percent in the United 
States general population, subsequently affecting 5 to 13 percent of patients in the 
primary care setting (Maurer & Darnall, 2012). Depression is attributed to $43 billion in 
medical care and costs (Maurer & Darnall, 2012). While depression can be present in the 
absence of other conditions, there are some that have a higher incidence of depression 
such as chronic medical illness, chronic minor daily stress, chronic pain syndrome, 
family history of depression, female sex, low income job/loss, low self-esteem, low social 
support, prior history of depression, single/divorced/widowed, traumatic brain injury, and 
younger age (Maurer & Darnall, 2012). Increased mortality, worsening preexisting 
conditions such as cardiovascular disease and diabetes, can lead to suicide (Hollender, 
2014). 
Stroke is a common medical condition, with over 600,000 new cases annually 
(Whyte & Muslant, 2002; American Heart Association, 2015). In the United States, there 
are 4.5 million survivors, however this figure is projected to increase as the management 
of stroke continues to improve (Whyte & Muslant, 2002; American Heart Association, 
2015). Stroke results in changes in an individual’s life, there can be a significant number 
of losses related to health, occupation, social role and independence. Subsequently major 
depression is a common occurrence after a stroke. Approximately one third of stroke 
victims will suffer from post stroke depression with a peak prevalence within the first 
year (American Heart Association Stroke Council, 2017). Post stroke depression is 
thought to complicate and delay stroke rehabilitation, subsequently leading to poorer 
outcomes (Kouwenhoven, Kirkevold, Engedal, & Kim, 2011). Despite the prevalence of 
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post stroke depression and recommendations for screening, there remains a lack of 
clinical practice guidelines to facilitate the process and standardization of care. 
The project setting was located within a healthcare system in the southern United 
States. The healthcare system is comprised of 11 hospitals, 15 urgent care centers, 16 
satellite diagnostic imaging centers, three health parks and a pediatric center, one adult 
congregate living facility, three skilled nursing facility, and three inpatient hospices. The 
organizations are either Primary Stroke Center Certified or Comprehensive Stroke Center 
Certified as designated by the Joint Commission, the differences were discussed earlier in 
the project. As with any other organization, the project setting has a mission and vision. 
The mission is to create and deliver high quality hospital, physician and other healthcare 
related services that improve the health and well-being of the individuals and 
communities it serves. In conjunction with the mission, the vision of the organization is 
to deliver world-class healthcare. 
Role of the DNP Student 
The DNP project was a fulfillment requirement of Walden University, as such the 
student was the leader of the project. The DNP project leader was responsible for the 
primary authorship of the proposal, project design and implementation, data analysis, and 
summarization. Factors considered when choosing a focus for the DNP project was the 
patient population in my professional practice and the practices between various entities 
within the same healthcare system. Another influencing factor to the DNP project topic is 
being a Clinical Nurse Specialist (CNS). A CNS is a Master’s or Doctoral prepared 
Advanced Practice Nurse whose primary function is to improve outcomes in patient care. 
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The CNS has expertise in clinical practice, patient education, research and consultation to 
impact the three spheres of influence: patient care, nursing and systems (Sparacino & 
Cartwright, 2009). As the CNS in neurosciences, there is a constant monitoring of clinical 
practice in addition to staying abreast of evidence and/or guidelines of 
regulatory/authority bodies. In the recent American Heart Association/American Stroke 
Association (AHA/ASA) guidelines there is a recommendation that post stroke patients 
be screened for depression (Powers et al., 2018). However, the guidelines do not specify 
if depression screening is recommended in the stroke patient receiving care at a 
comprehensive stroke center or primary stroke center as part of the acute management 
phase. Therefore, the inference is that all post stroke patients regardless of the stroke 
center designation should be screened. Development of clinical practice guidelines for 
depression screening will improve standardization, consistency, and care in poststroke 
patients across the healthcare system rather than just a single entity. 
Summary 
The review of the literature has supported that screening for depression in post 
stroke patients can improve early identification and treatment in that population. The 
utilization of an evidence-based tool related to depression screening in the post stroke 
patient will improve quality of life, self-care, self-efficacy and functional outcomes. 
However, without a clinical guideline there is a decreased likelihood that depression 
screening will occur. Section 2 of this project presented an overview of stroke and the 
connection to depression, John Hopkins Evidence-Based practice model as the 
framework, and the role of the DNP student in carrying out the evidence-based project. 
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Section 3 discussed the literature search of depression, depression screening and the 
approach to the DNP project. 
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Section 3: Collection and Analysis of Evidence 
Introduction 
The purpose of this project was to develop a clinical practice guideline for 
depression screening in poststroke patients. The overall goal of this project was to 
develop a clinical practice guideline for depression screening, which will ultimately 
facilitate early identification and treatment if warranted in post stroke patients. 
Section 3 outlines the development process of the project. This section reviews 
the practice-focused question, sources of evidence reviewed regarding the topics of 
depression and depression screening, the project’s approach, population/sampling, data 
collection, data analysis, project evaluation, and summary. 
Practice-Focused Question 
The local problem that the DNP project addressed is the lack of depression 
screening in poststroke patients. The following practice-focused question guided my 
project: What are current evidence-based approaches for screening for depression in the 
post stroke patient? The goal of this project was the development of a clinical practice 
guideline for depression screening in a primary stroke center to screen for depressive 
symptoms in poststroke patients. After the conclusion of development of the clinical 
practice guideline, the outcomes included the following: 
Outcome 1: Literature Review Matrix: Depression screening in patients with 
chronic conditions with comprehensive review of the literature  
Outcome 2: Development of a clinical practice guideline for post stroke patients 
with a validated tool  
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Outcome 3: Approved clinical practice guideline by an expert panel for 
depression screening in post stroke patients 
The summation of outcomes and dissemination to program stroke coordinator and 
other stakeholders will occur after graduation from Walden University.  
The following terms were used in developing the project: 
Clinical guidelines: Standardized current national and international guidelines for 
the assessment, diagnosis, and management of patient conditions that are developed by 
clinical guideline panels or professional groups to improve the outcomes of care and 
promote evidence-based health care (Grove, Burns, & Gray, 2013). 
Protocol: A detailed plan of scientific or medical experiment, treatment or 
procedure (Merriam-Webster, n.d.). 
Poststroke depression: The onset of persistent sadness or loss of interest in the 
acute phase of a stroke, a time span from 2 weeks up to 1 year following a stroke (Buga 
et al., 2015).   
Sources of Evidence 
The sources that were used for the review were recent evidence-based projects 
and peer-reviewed literature. To facilitate development of the clinical practice guideline, 
I used the current clinical guidelines from the American Heart/Stroke Association, the 
UPTSF, and other evidence-based guidelines. Information was used to define depression 
and onset of depression in poststroke patients, and identify validated assessment tools, 
treatment recommendations, and follow up which will be included in the clinical practice 
guideline. These sources are currently used to define some aspects of care in the stroke 
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patient within the organization. Incorporating them into the clinical practice guideline 
provided additional support for implementation in the organization. Collecting and 
analyzing this evidence was imperative to discovery of evidence-based approaches to 
depression screening in post stroke patients for cumulation into a clinical practice 
guideline. 
Published Outcomes and Research 
I performed a literature review for the most current and relevant information 
related to this project, which is depression screening in poststroke patients. The following 
electronic databases were utilized: The Cumulative Index to Nursing and Allied Health 
Literature, Cochrane Database of Systematic Reviews, Cochrane Central Register of 
Controlled Trials, Cochrane Methodology Register, and PsycARTICLES. The keywords 
that were used to retrieve sources of evidence included: depression and post stroke, 
depression screening, depression screening tools, post stroke, evidence based-guidelines 
and protocols, and John Hopkins Evidenced-Based Practice Model. The search was 
limited to articles from 2000 to 2016 which were relevant to the project.  
Evidence Generated for the Doctoral Project 
Participants 
Once the clinical practice guideline was developed, an expert panel was formed. 
Qualifications for an individual to be considered for the panel was contingent on practice 
specialty or job functions, such as neurologist or stroke program director respectively. 
The expert panel was limited to a maximum of five participants. The second panel 
consisted of the potential end users of the clinical practice guideline, bedside clinician, 
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stroke program coordinator, a clinical nurse specialist, and unit director. It is important 
that the end user was engaged in the review of the guideline as to ensure usability. All 
participants were contacted via email for participation. 
Procedures 
The initial step for developing a clinical practice guideline was the identification 
of the problem the guideline will address. As previously discussed, the practice problem I 
observed was the lack of depression screening in poststroke patients at the project site. 
The practice question developed is what are current evidence-based approaches for 
screening for depression in the poststroke patient? I developed evidence selection criteria 
for the clinical practice guideline. Selection criteria used any previously published 
guidelines or recommendations regarding depression screening and depression screening 
in the poststroke population. Other pertinent selection criteria were evidence that 
contained adults, ages 18 and older, stroke survivors, and inpatient care settings and 
depression tool. The selection criteria were organized in a chart using Microsoft Word 
(Appendix A). The evidence included peer-reviewed, original research studies and 
evidence-based projects. The evidence was evaluated for the selection criteria; however, 
the evidence was not to be eliminated if all criteria are not met. Importance was placed on 
setting, population age, and depression screening tool. For evidence missing elements of 
the selection criteria, the level of evidence was of heavier significance. I used a letter 
coding system to describe the feedback received from the expert panelists. The evidence 
was appraised using the JHNEBP levels of evidence. Following the appraisal of the 
evidence, it was synthesized and used to develop the clinical practice guideline. Once the 
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clinical guideline was developed, the expert panelist was contacted via email with the 
link to the feedback form. The feedback from the expert panelist was collected using the 
standard instrument, the AGREE II. AGREE II is a 23-item instrument (Appendix D) that 
is divided into six quality domains with a 7- point Likert scale to score each item that was 
used to collect recommendations from the expert panelist (AGREE Next Steps 
Consortium, 2013). The Likert scale has a range of 1 to 7, with 1 meaning strongly 
disagree and 7 meaning strongly agree. AGREE II has an acceptable reliability in most 
domains with Cronbach’s alpha 0.64-0.88 with 95% of appraisers finding the tool useful 
for evaluating guidelines (Brouwers et al., 2010). The panelist was sent an electronic link 
via email to the standard instrument. This facilitated anonymity of the panelist. All 
information was stored in a secured location with access restricted to me. I retrieved the 
feedback from the AGREE II website and scores of the clinical practice guideline. After 
the revisions were completed, the clinical practice guideline was submitted to the second 
group to discuss content validation and usability. At the conclusion of the feedback from 
the expert panelist and end-user/key stakeholders, a final report of the clinical practice 
guideline will be developed and disseminated. 
Protections 
I collaborated with the clinical site mentor to identify panelist for the project. 
Once identified panelist were contacted in the manner previously described. To protect 
each panelist identity, each participant was emailed the identical communication 
separately, there were no group email communication. Email communications were saved 
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to a password protected folder. Absence of feedback within the AGREE II instrument 
was considered as voluntary withdrawal from the project.  
Once I obtained committee approval, the project was submitted to the 
University’s IRB review for approval. The University’s IRB role was to review the 
project for any potential human subject violations or any breaches in data collection in 
accordance to institutional regulations. Following the approval from University IRB, the 
project was submitted to the project site’s IRB for review and approval. The role of the 
project site’s IRB was to ensure the project complies with the organization’s research 
requirements and human subject protection. 
An ethical dilemma I navigated is bias. Bias means to slant away from the true or 
expected (Grove et al., 2013, p. 197). Due to the time spent researching the evidence, I 
had developed a belief the depression screening in poststroke patients should be part of 
the management phase in the acute care setting. To mitigate the bias to depression 
screening, the I used the recommendations from the expert panel to support use of the 
clinical practice guideline. 
Analysis and Synthesis 
Approach 
The Appraisal of Guidelines Research and Evaluation (AGREE) II was used to 
develop the clinical practice guideline. This project targeted hospital patients admitted to 
an acute care stroke unit in a primary stroke certified designated hospital. I obtained IRB 
approval, 01-09-19-0558331 from the University and the project site (see Appendix B). 
Permission was also obtained from leadership at the project site prior to implementation. 
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I developed clinical practice guidelines based on current evidence. Once the clinical 
practice guideline was developed, I sought out panelist to participate on the expert panel 
to provide feedback and recommendations. Panelist considered were relevant 
professionals such as a mental health provider, neurology provider, and an advanced 
practice nurse, such as a clinical nurse specialist. Potential panelists were contacted via 
email to serve as participants using the University’s approved disclosure to expert 
panelist form for anonymous questionnaires (see Appendix C). Participation was 
voluntary. Panelist were sent the AGREE II instrument and a link to the electronic 
guideline to review. Once the AGREE instrument was returned by the expert panel, I 
revised the clinical practice guideline according to the received recommendations. The 
next step was to identify a group of key stakeholders including neuroscience nurses, 
stroke program coordinator, clinical nurse specialist to present the revised guideline to for 
validation and usability. To identify the key stakeholders, I used the host facility 
organizational chart in addition to the administration list. Final feedback from end users 
will be compiled in a report that will be disseminated to key stakeholders.  
Data Analysis 
Data analysis was conducted using the AGREE II score calculator (Appendix E). 
I analyzed each of the six domain scores and overall assessment of the clinical practice 





At the completion of the EBP project a summative evaluation was conducted. The 
summary consisted of the individual appraisers scoring and overall assessment of the 
clinical practice guideline. Recommendations for use was also included in the summative 
evaluation. The evaluation will be presented to the stakeholders of the organization 
following conferral of the student’s doctorate degree.  
Summary 
Section 3 provided a review of the DNP project, detailed overview of method of 
the literature search using the key terms depression and stroke, evidence-based guidelines 
and protocol and depression, depression screening, depression screening tools, depression 
screening. The methodology of the DNP project was also discussed in this section. 
Section four will discuss the findings, implications, recommendations, strength and 
limitations of the clinical practice guidelines. 
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Section 4: Findings and Recommendations 
Introduction 
Depression poststroke affects approximately one third of stroke survivors 
(American Heart Association Stroke Council, 2017). Depression has been demonstrated 
to have a significant impact on the quality of life, functional recovery, morbidity, and 
mortality of the poststroke patient (Robinson-Smith et al., 2000, Yildirim et al., 2013). 
Powers et al. (2018), on behalf of the American Heart/Stroke Association, made 
recommendation for depression screening for poststroke patients in the 2018 Guidelines 
for the Early Management of Patients with Acute Ischemic stroke. Despite this 
recommendation, there is a lack of guidance on which validated tools to use, address 
optimal timing for screening, and appropriate healthcare personnel to perform the 
depression screening in the poststroke patient. 
The DNP project site, a multicenter healthcare system located in the southern 
United States, used the guidelines of the American Heart/Stroke Association (see Powers 
et al., 2018) in addition to standards of care of The Joint Commission (see The Joint 
Commission, 2018) in the delivery of care of the stroke patient. However, the 
organization lacks mechanisms and or processes in place to perform depression screening 
in poststroke patients. The DNP project sought out to address this gap in practice. The 
goal of this project was the development of a clinical practice guideline for depression 




As mentioned earlier in this paper, the sources that were used for the review were 
recent evidence-based projects and peer-reviewed literature. I used current clinical 
guidelines from the American Heart/Stroke Association, the UPTSF, and other evidence-
based guidelines. Information from sources were used to define depression and the onset 
of depression in poststroke patients, and to identify validated assessment tools, treatment 
recommendations, and follow-up, which will be included in the clinical practice 
guideline. The sources of evidence were then appraised using the JHNEBP research 
appraisal method, reflected in Appendix A. The evidence from the sources were then 
synthesized to develop the clinical practice guidelines (Appendix F). 
Findings and Implications 
The project was carried out as specified in the procedure. Five individuals from 
the project site were invited to participate on the expert panel. Four panelists completed 
feedback using the AGREE II instrument. Participation was voluntary, lack of response 
from the fifth panelist was assumed as a withdrawal of participation. The AGREE II 
instrument uses a Likert scale scoring 1-7 that the expert panelist used to rank items in 
each domain (Table 1).  
A quality score was then calculated for each domain. There are various methods 
on which domains are highest priority, depending on the preference of the users. For the 
intent of this DNP project, all domains are of equal significance, therefore all domains 
have a calculated quality score. Threshold for the quality score is 70%, which means 
quality scores 70% or higher signify a high-quality guideline. The quality scores for each 
domain are Domain 1 Scope and Purpose: 89%, Domain 2 Stakeholder Involvement: 
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68%, Domain 3 Rigor and Development: 72%, Domain 4 Clarity of Presentation: 93%, 
Domain 5 Applicability: 71%, and Domain 6 Editorial Independence: 81%. The overall 
assessment of the clinical practice guidelines was 79%, which indicated high quality 
guidelines based on the ratings of the expert panel. Although the overall assessment 
revealed a high-quality clinical practice guideline, there are opportunities for revisions in 
three of the domains: stakeholder involvement, rigor and development, and applicability 
with quality scores of 68%, 72% and 71% respectively. The expert panelists were also 
asked to provide an additional overall assessment and recommendation for use of the 
clinical practice guidelines. For the final category there is not a quality score applied as 
with each domain, but rather it is reported as a raw score based on the number of 
panelists that responded yes, yes with modifications, or no for recommendation for use of 
the clinical practice guidelines.  All panelists responded yes to a recommendation for use, 
however one (25%) panelist responded “yes” and three (75%) responded “yes with 
modifications”. None of the panelist responded “no”. 
An unanticipated limitation of the DNP project were challenges in obtaining 
feedback from the second panel of end users prior to the conclusion of the 
implementation phase. Multiple attempts were made but I was unsuccessful in obtaining 
meeting times from identified participants of the second group due to scheduling conflicts 
and organizational priorities such Joint Commission survey visits and disaster drills. This 
limitation delayed providing the summation report for the leaders in the organization as 
well as vetting the usability with the end users. 
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Another limitation was the lack of narrative comments or feedback from the 
expert panelists when rating scores were low on the Likert scale, (below 5). This lack of 
feedback prohibited me from specifically addressing the deficit. Although there was 
strong support recommending the guidelines for use with modifications, limitations on 
revisions exist around the lack of details of required modifications. 
The response rate of the expert panelist is another limitation. As stated previously, 
five experts were contacted via email to participate in the expert panel. However, only 
four of the five completed the instrument. The panelist who did not complete the AGREE 
II instrument on the clinical practice guidelines served in the role as a neurologist. The 
lack of feedback from a medical doctor affects the willingness of leaders of the 
organization to implement the practice guidelines.  
The clinical practice guideline lacked treatment options for those who were 
identified to have depressive symptoms, which is a limitation of the project. This area 
was excluded from the clinical practice guideline because it would significantly lengthen 
the guidelines which had the potential to impact expert panelist participation. 
Potential implications include depression screening in poststroke patients within 
the project site using the clinical practice guidelines. The incorporation of the clinical 
practice guidelines in the clinical setting would provide standards on timing of depression 
screening, frequency intervals, who should perform the screening, and what tools to 
utilize for depression screening. Admitted stroke patients would receive the standard of 
care as recommended by the American Heart/Stroke Association, promoting early 
identification and ultimately treatment. Another implication within the organization is the 
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increased engagement from nursing in proactively assessing for signs of depression 
through performance of depression screening. Additionally, patients and caregivers 
would have increased awareness lessening the negative stigma around depression. For 
healthcare systems such as the project site, implementation of depression screening 
clinical practice guidelines increases standardization across the system. It also improves 
communication with community providers. Additionally, upon discharge overall 
effectiveness is achieved improving the assessment and management of depression in the 
poststroke patient.  
An outcome of doctorate education is the ability to influence positive social 
change. The successful implementation of the clinical practice guideline has the potential 
to expand beyond the project site. Through dissemination at conferences, forming 
collaborative relationships with other colleagues on the subject of depression will 
facilitate the ultimate goal of developing the DNP project clinical practice guidelines into 
national practice guidelines. Development and implementation of national practice 
guidelines for depression screening poststroke will eliminate the ambiguity surrounding 
timing, screening tools, who performs depression screening, management and treatment 
for those patients who screen positive for depression and providing organizations to 
enhance care delivered to poststroke patients. This enhanced care has the potential to 
improve the quality of life, mortality, and morbidity of the stroke survivor.  
Recommendations 
Although the clinical practice guidelines were developed as a part of the DNP 
project, I received a strong recommendation for use by the expert panelist. Additionally, 
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feedback from the end users will be a critical component of successful implementation. 
The clinical practice guidelines will need revisions based on the recommendations prior 
to sharing with end users. Once end user feedback is obtained, future solutions include 
implementation of the clinical practice guidelines with a pilot study. Implementation of 
the guidelines will need to be supported with educational in services and training 
regarding depression screening as this will be a change in current practice. Those aspects 
were not included as part of the DNP project and will need to be developed. 
Strengths and Limitations of the Project 
The DNP project, development of clinical practice guidelines for depression 
screening poststroke has mentionable strengths. The response rate of the expert panelist, 
80% yielded a high-quality review of the clinical guidelines. The high ratings, in 
conjunction with a recommendation for use with modifications is another identified 
strength. Limitations of the project include absence of feedback from a neurologist, end 
user feedback, and absence to improve guidelines because of missing comments or 
details. 
Recommendations for future projects would be to revise guidelines according to 
suggestions of the expert panel. An additional recommendation is to collaborate with the 
panel to ensure the inclusion of treatment options into clinical practice guidelines. The 
clinical practice guidelines provide guidance surrounding depression screening in 






Expert Panelist Ratings 
  Appraiser 1 Appraiser 2 Appraiser 3 Appraiser 4 
Domain         
Domain 1: Scope 
and Purpose 
        
Item 1 7 6 7 6 
Item 2 6 6 6 5 




        
Item 4 7 4 7 3 
Item 5 7 3 7 1 
Item 6 7 7 7 1 
Domain 3: Rigor 
of Development 
        
Item 7 7 6 6 6 
Item 8 7 1 6 5 
Item 9 6 4 3 6 
Item 10 7 4 2 6 
Item 11 7 6 6 6 
Item 12 7 5 6 6 
Item 13 7 5 4 7 




        
Item 15 7 7 7 6 
Item16 6 7 7 6 
Item 17 7 7 7 5 
Domain 5: 
Applicability 
        
Item 18 6 5 5 7 
Item 19 7 5 7 5 
Item 20 7 3 6 6 




        
Item 22 7 7 7 6 
Item 23 7 1 7 5 
Overall 
Assessment 
7 5 6 5 
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Section 5: Dissemination Plan 
As mentioned in an earlier part of this paper, the project will be disseminated to 
the stakeholders of the organization in a report after graduation. This report will include 
the expert panel ratings and recommendation, as well as the end user feedback. Future 
attempts will be made to coordinate with the end user group to obtain feedback, 
following completion of the DNP program. 
The summation report will be shared with the stroke program directors, medical 
directors, and organization accreditation specialists. Subsequent dissemination to the 
larger leadership team and nursing practice councils will be necessary for full support of 
the clinical practice guidelines. 
In consideration of advancement to the nursing profession, dissemination of the 
clinical practice guidelines is recommended to the local and or regional stroke alliance 
organizations. Secondly, dissemination should occur at national and stroke-related 
conferences. Magnet conferences would be a third venue as those are heavily focused on 
the impact nurses have on the outcomes of patients. The ultimate venue would be at the 
International Stroke Conference, which occurs annually at various locations within the 
United States. 
Analysis of Self 
The DNP project has provided me with many opportunities to function in 
different capacities. One role is that of practitioner. I am a clinical nurse specialist, which 
is a form of a practitioner. In this role, I constantly must investigate strategies to improve 
the health of the stroke population and the best ways to incorporate those strategies into 
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clinical practice. The scholar role challenged me throughout the DNP project in finding 
relevant sources and critically appraising the evidence. Prior to initiation of the DNP 
project, I identified as being a novice scholar, however by the conclusion of the project, I 
feel I have progressed to being competent. As project manager, I designed the project, 
projected a timeline, “engaged in selling” the concept, implemented the project, obtained 
and analyzed findings, and concluded with a report of the findings. Generally, a project 
manager collaborates with a team of individuals and delegates different aspects of a 
project; however, because I elected not to designate a team, I was accountable for all 
aspects of the project. That degree of responsibility required me to be organized, and use 
calendars, trackers, and other available resources. All the roles have facilitated growth in 
collaboration with members in other roles as well as other organizations, which I was not 
accustomed to. Long term, I want to continue to advance development of clinical practice 
guidelines for depression screening in poststroke patients through forming collaborative 
relationships with other professionals involved with care and outcomes of the stroke 
patient. 
Throughout the project, I identified areas of growth opportunities. A significant 
lesson I learned is to always identify key stakeholders and involve them in the initial 
planning stages, including the development of the idea. Awareness of those key 
individuals can have a significant impact on required approvals. Another opportunity was 
formulating necessary relationships when partnering with other organizations. It is 
important to comprehend the individual’s role within the organization and his/her 
priorities. Although project site approval had been granted by the project site, I made 
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several trips to meet with potential participants on the expert panel to obtain buy-in. A 
final lesson I learned is to be accepting that the journey is not smooth. Obstacles will 
happen that will impact the original plan of the project such as unforeseen challenges in 
scheduling conflicts that prevent the group from meeting as initially planned. However, 
the project must come to an end, therefore said barriers become a limitation. It is not the 
end, but just a detour in the journey to improve patient care while simultaneously 
impacted the nursing profession.  
Summary 
Stroke is the fifth leading cause of death in the United States but remains the 
leading cause of disability (American Heart Association, 2015). This population of 
individuals, the poststroke patient, has a higher propensity of developing depression 
poststroke (American Heart Association Stroke Council, 2017). Depression poststroke 
can have a negative impact on the quality of life and increase mortality and morbidity of 
the stroke survivor (Buga et al., 2015, Kouwenhoven et al., 2011, Robinson-Smith et al., 
2000). Despite the prevalence of depression poststroke in the evidence and 
recommendations for screening, there lacks clinical practice guidelines for depression 
screening of the poststroke patient. The aim of this DNP project was to address the gap in 





AGREE Next Steps Consortium. (2013). The AGREE II Instrument [Electronic version]. 
Retrieved from http://www.agreetrust.org 
American Association of Colleges of Nursing. (2006). The essentials of doctoral 
education for advanced nursing practice. Retrieved from 
http://www.aacn.nche.edu/publications/position/DNPEssentials.pdf. 
American Heart Association. (2015). Heart Disease and Stroke Statistics—2016 Update 
A Report from the American Heart Association. Circulation, 133, e38-e360. 
https://doi.org/10 .1161/CIR .0000000000000350 
American Heart Association Stroke Council. (2017). Post-stroke depression; A scientific 
statement for healthcare professionals from the American Heart 
Association/American Stroke Association. Stroke, 48, e30-e43. 
https://doi.org/10.1161/STR.0000000000000113 
Andersen, H. E., Schultz-Larsen, K., Kreiner, S., Forchhammer, B. H., Eriksen, K., & 
Brown, A. (2000). Can readmission after stroke be prevented? Results of a 
randomized clinical study; a post discharge follow up service for stroke survivors. 
Stroke, 31, 1038-1045. Retrieved from http://stroke.ahajournals.org 
Babkair, L. A. (2017). Risk factors for poststroke depression: An integrative review. 
Journal of Neuroscience Nursing, 49(2), 73-84. 
https://doi.org/10.1097/JNN.0000000000000271 
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Fedar, G., ... 
Markarski, J. (2010a). AGREE Next Steps Consortium Development of the 
 
48 
AGREE II part I assessment of validity of items and tools to support application. 
Canadian Medical Association Journal, 182(10), E472-8. Retrieved from 
www.agreetrust.org 
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Fedar, G., ... 
Markarski, J. (2010b). AGREE Next Steps Consortium Development of the 
AGREE II part I performance usefulness and areas for improvement. Canadian 
Medical Association Journal, 182(10), 1045-52. Retrieved from 
www.agreetrust.org 
Buchko, B. L., & Robinson, L. E. (2012). An evidence-based approach to decrease early 
post-operative urinary retention following urogyneologic surgery. Urologic 
Nursing, 32(5), 260-273.  
Buga, A. M., Filfan, M., George, B., & Popa-Wagner, A. (2015). The impact of aging on 
post stroke depression. In P. Singh & S. Mastana (Eds.), Depression; A silent 
culprit in health and disease (pp. 51-67). [Adobe Digital Editions version]. 
Retrieved from http://ebooks.bethamscience.com/book/9781681081458 
Campos, S. (2011). Evidence-based practice vs best practice. Retrieved from 
http://www.communitygrantsnow.com/2011/08/30/evidence-based-practices-vs-
best-practices/ 
Damush, T., Jia, H., Reid, L., Qin, H., Cameon, R., Plue, L., & Williams, L. (2008). Case 
finding algorithm for post-stroke depression in the veterans; health administration. 




Dillman, J., Mancas, B., Jacoby, M., & Ruth-Sahd, L. (2014). A review of the literature 
differences in outcomes for uninsured versus insured critically ill patients 
opportunities and challenges for critical care nurses as the patient protection and 
Affordable Care Act begins open enrollment for all Americans. Dimensions of 
Critical Care Nursing, 33(1), 8-14. 
https://doi.org/10.1097/DCC.0000000000000012 
Egede, L. E., & Ellis, C. (2010). Diabetes and depression: Global perspectives. Diabetes 
Research and Clinical Practice, 87, 302-312. 
https://doi.org/10.1016/j.diabres.2010.01.024 
Grove, S. K., Burns, N., & Gray, J. R. (2013). The practice of nursing research; 
Appraisal, synthesis, and generation of evidence (7th ed.). St. Louis, Missouri: 
Elsevier Saunders. 
Hermann, N., Seitz, D., Fishcer, H., Saposnik, G., Calzavara, A., Anderson, G., & 
Rochon, P. (2011). Detection and treatment of post-stroke depression; results 
from the registry of the Canadian stroke network. International Journal of 
Geriatric Psychiatry, 26, 1195-1200. https://doi.org/10.1002/gps.2663 
Hollender, K. (2014). Screening, diagnosis, and treatment of post-stroke depression. 
Journal of Neuroscience Nursing, 46(3), 135-141. 
https://doi.org/10.1097/JNN.0000000000000047 
Huang, H., Chaung, Y., Hsuch, Y., Lin, P., Lee, B., & Chen, C. (2014). Depression in 
older residents with stroke living in long term care facilities. Journal of Nursing 
Research, 22(2), 111-118. https://doi.org/10.1097/jnr.0000000000000028 
 
50 
Jia, H., Chumbler, N. R., Wang, X., Chaung, H. C., Damush, T. M., Cameron, R., & 
Williams, L. S. (2010). Racial and ethnic disparities in post stroke depression 
detection. International Journal Geriatric Psychiatry, 25, 298-304. 
https://doi.org/10.1002/gps.2339 
Joubert, J., Reid, C., Joubert, L., Barton, D., Ruth, D., Jackson, D., ... Davis, S. M. 
(2006). Risk factor management and depression post-stroke: The value of an 
integrated model of care. Journal of Clinical Neuroscience, 13, 84-90. 
https://doi.org/10.1016,jocn.2005.07.003 
Kirkil, G., Deveci, F., Deveci, S. E., & Atmaca, M. (2015). Anxiety and depression 
symptoms in patients with chronic obstructive pulmonary disease. Bulletin of 
Clinical Psychopharmacology, 25(2), 151-161. 
https://doi.org/10.5455/bcp.20121130122137 
Klinedinst, N. J., Dunbar, S. B., & Clark, P. C. (2012). Stroke survivor and informal 
caregiver perceptions of poststroke depressive symptoms. Journal of 
Neuroscience Nursing, 44(2), 72-81. 
https://doi.org/10.1097/JNN.0b013e3182477944 
Kouwenhoven, S. E., Kirkevold, M., Engedal, K., & Kim, H. S. (2011). Depression in 
acute stroke: prevalence, dominant symptoms and associated factors. A 
systematic literature review. Disability and Rehabilitation, 33(7), 539-556. 
https://doi.org/10.3109/09638288.2010.505997 
Kouwenhoven, S., Kirkevold, M., Engedal, K., & Kim, H. (2012). Living a life in shades 
of grey; experiencing depressive symptoms in the acute phase after stroke. 
 
51 
Journal of Advanced Nursing, 68(8), 1726-1737. https://doi.org/10.1111/j.1365-
2648.2011.05855.x 
Lerdal, A., Bakken, L. N., Rasmussen, E. F., Beiermann, C., Ryen, S., Pynten, S., ... Kim, 
H. S. (2011). Physical impairment, depressive symptoms and pre-stroke fatigue 
are related to fatigue in the acute phase after stroke. Disability and Rehabilitation, 
33(4), 334-342. https://doi.org/10.3109/09638288.2010.490867 
Lightbody, C., Baldwin, R., Connolly, M., Gibson, B., Jawaid, N., Leathley, M., ... 
Watkins, C. (2007). Can nurses help identify patients with depression following a 
stroke? A pilot study using two methods of detection. Journal of Advanced 
Nursing, 57(5), 505-512. https://doi.org/10.1111j.1365-2648.2006.04135.x 
Maurer, D. M., & Darnall, C. R. (2012). Screening for depression. American Family 
Physician, 85(2), 139-144. Retrieved from http://www.aafp.org/afp 
McIntosh, C. (2017). A depression screening protocol for patients with acute stroke: A 
quality improvement project. Journal of Neuroscience Nursing, 49(1), 39-48. 
https://doi.org/10.1097/JNN.0000000000000231 
Melrose, S. (2016). Post-stroke depression How can nurses help. Canadian Nursing 
Home, 27(1), 5-9. 
Merriam-Webster. (n.d.). Protocol. In Medical Dictionary. Retrieved from 
https://www.merriam-webster.com/dictionary/protocol#medicalDictionary 
Mori, C. (2015). Implementing evidence-based practice to reduce infections following 




Newhouse, R. P., John Hopkins University, Sigma Theta Tua International, & John 
Hopkins Hospital (2007). Johns Hopkins Nursing Evidence-based Practice Model 
and Guidelines.  
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., 
Becker, K., ... Tirschwell, D. L. (2018). 2018 Guidelines for the early 
management of patients with acute ischemic stroke; A guideline for healthcare 
professionals from the American Heart Association/American Stroke Association. 
Stroke, 49(3), e46-99. https://doi.org/10.1161/STR.0000000000000158 
Robinson-Smith, G., Johnston, M., & Allen, J. (2000). Self-care, self-efficacy, quality of 
life, and depression after stroke. Physical Medicine and Rehabilitation, 81, 460-
464. https://doi.org/10.1053/MR.2000.3863 
Rosenfeld, R. M., & Shiffman, R. N. (2009). Clinical practice guideline development 
manual: a quality-driven approach for translating evidence into 
action. Otolaryngology--head and neck surgery : official journal of American 
Academy of Otolaryngology-Head and Neck Surgery, 140(6 Suppl 1), S1–S43. 
doi:10.1016/j.otohns.2009.04.015 
Siu, A., & US Preventive Services Task Force (2016,). Screening for depression in adults 
US Preventive Services Task Force recommendation and statement. Journal of 
American Medical Association, 315(4), 380-387. 
https://doi.org/10.1001/jama.2015.18392 
Sparacino, P. S., & Cartwright, C. C. (2009). Advanced Practice Roles: The operational 
definitions of Advanced practice nursing: The Clinical Nurse Specialist. In A. B. 
 
53 
Hamric, J. A. Spross, & C. M. Hanson (Eds.), Advanced Practice Nursing; An 
intergrative approach (4th ed. (pp. 349-379). St. Louis, Missouri: Saunders 
Elsevier. 
Stanfill, A., Elijovich, L., Baughman, B., & Conley, Y. (2016). A review and conceptual 
model of dopaminergic contributions to poststroke depression. Journal of 
Neuroscience Nursing, 48(5), 242-246. 
https://doi.org/10.1097/JNN.0000000000000240 
The Joint Commission. (2017). Joint Commission E-edition. Certification standards. 
Retrieved from https://e-dition.jcrinc.com/MainContent.aspx 
The Joint Commission. (2018). Joint Commission E-edition Certification standards. 
Retrieved from https://e-dition.jcrinc.com/MainContent.aspx 
US Department of Health & Human Services. (2012). U.S. Preventive Services Task 
Force (USPSTF): An introduction. Retrieved from 
http://www.ahrq.gov/professionals/clinicians-providers/guidelines-
recommendations/uspst/index.html 
Whyte, E. M., & Mulsant, B. H. (2002). Post stroke depression: Epidemiology, 
pathophysiology, and biological treatment. Biological Psychiatry, 52, 253-264. 
Williams, L., Ofner, S., Yu, Z., Beyth, R., Plue, L., & Damush, T. (2011). Pre-post 
evaluation of automated reminders may improve detection and management of 




Yildirim, A., Asilar, R. H., Bakar, N., & Demir, N. (2013). Effect of anxiety and 
depression on self-care agency and quality of life in hospitalized patients with 
chronic obstructive pulmonary disease: a questionnaire survey. International 
Journal of Nursing Practice, 19, 14-22. https://doi.org/10.1111/ijn.12031 
 
55 
Appendix A: Evidence Organization Chart 
Authors Existing 
guideline 








Amaricai, E., & 





























Das, J., & G.K., 
R. (2018). 










Ettema, R. G., 
Grobbee, D. E., 
& Schuurmans, 
M. J. (2013). 












Jackson, D., ... 
Davis, S. M. 
(2006). 










J., Dunbar, S. 
B., & Clark, P. 
C. (2012). 











Baker, J., & 
O’Malley, H. 
(2010) 




























Li, J., Oakley, L. 
D., Brown, R. 
L., Li, Y., Ye, M., 
& Luo, Y. 
(2016). 













Leathley, M., ... 
Watkins, C. 
(2007) 















L., Moreno, M. 
F., Dablado, S., 
& Hernandez, 
J. (2015). 














































N NA NA Post stroke various C 
Powers, W. J., 
Rabinstein, A. 
A., Ackerson, 
T., Adeoye, O. 
M., 
Bambakidis, N. 
C., Becker, K., 
... Tirschwell, 
D. L. (2018). 














































& Conley, Y. 
(2016) 
N NA 18 or older Stroke 
patients 
NA B 
Swartz, R. H., 
Bayley, M., 
Lanctot, K. L., 
Murray, B. J., 
Cayley, M. L., 
N Various 18 or older stroke NA C 
 
58 
























Wang, E. Y., 
Meyer, C., 
Graham, G. D., 






































































Appendix E: AGREE II Score Calculator 
Seven-point AGREE II Score 
Calculator 
You must fill in ALL of the Question ratings from an appraiser for 
the Domain score to be accurate. *Note: Please use the AGREE II 
User's Manual for full instructions. 
Total # of 
Appraisers Appraiser 
0 1 2 3 4 
     Domain 1 - 
Scope and 
Purpose 
        
Q1 - The overall 
objective(s) of the 
guideline is (are) 
specifically described. 
        
Q2 - The health 
question(s) covered by 
the guideline is (are) 
specifically described.  
        
Q3 - The population 
(patients, public, etc.) 
to whom the guideline 
is meant to apply is 
specifically described.  











Caution: Empty Cells 
        
Domain 1 Score for 
0 Appraiser(s): 
 
    
Domain 2 - 
Stakeholder 
Involvement 
        
Q4 - The guideline 
development group 
includes individuals 
from all relevant 
professional groups.  
        
Q5 - The views and 
preferences of the 
target population 
(patients, public, etc.) 
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have been sought.  
Q6 - The target users 
of the guideline are 
clearly defined.  











Caution: Empty Cells 
        
Domain 2 Score for 
0 Appraiser(s): 
 
    
Domain 3 - 
Rigour of 
Development 
        
Q7 - Systematic 
methods were used to 
search for evidence. 
        
Q8 - The criteria for 
selecting the evidence 
are clearly described.  
        
Q9 - The strengths 
and limitations of the 
body of evidence are 
clearly described.  
        
Q10 - The methods for 
formulating the 
recommendations are 
clearly described.  
        
Q11 - The health 
benefits, side effects, 




        
Q12 - There is an 
explicit link between 
the recommendations 
and the supporting 
evidence. 
        
Q13 - The guideline 
has been externally 
reviewed by experts 
prior to its publication. 
        
Q14 - A procedure for 
updating the guideline 
is provided.  











Caution: Empty Cells 
 
74 
        
Domain 3 Score for 
0 Appraiser(s): 
 
    
Domain 4 - 
Clarity of 
Presentation 
        




        
Q16 - The different 
options for 
management of the 
condition or health 
issue are clearly 
presented.  
        
Q17 - Key 
recommendations are 
easily identifiable 











Caution: Empty Cells 
        
Domain 4 Score for 
0 Appraiser(s): 
 
    
Domain 5 - 
Applicability         
Q18 - The guideline 
describes facilitators 
and barriers to its 
application. 
        
Q19 - The guideline 
provides advice and/or 
tools on how the 
recommendations can 
be put into practice. 
        
Q20 - The potential 
resource implications 
of applying the 
recommendations 
have been considered.  
        















Caution: Empty Cells 





    
Domain 6 - 
Editorial 
Independence 
        
Q22 - The views of the 
funding body have not 
influenced the content 
of the guideline. 
        
Q23 - Competing 
interests of guideline 
development group 
members have been 
recorded and 
addressed. 











Caution: Empty Cells 
        
Domain 6 Score for 
0 Appraiser(s): 
 
    
Overall Guideline 
Assessment         
1. Rate the overall 
quality of this 
guideline. Scoring: 
1(Least Quality) - 
7(Highest Quality) 
        
2. I would recommend 
this guideline for use. 
Scoring: "Yes",  "Yes, 
with modifications",  
"No" 
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